- Home
- Publications
- Publication Search
- Publication Details
Title
Chemical generation of bispecific antibodies
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 107, Issue 52, Pages 22611-22616
Publisher
Proceedings of the National Academy of Sciences
Online
2010-12-14
DOI
10.1073/pnas.1016478108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
- (2010) H. Hashizume et al. CANCER RESEARCH
- A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
- (2010) J. L. Brown et al. MOLECULAR CANCER THERAPEUTICS
- New treatment approaches in renal cell carcinoma
- (2009) Gaetano Facchini et al. ANTI-CANCER DRUGS
- Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment
- (2009) A. Constantinou et al. BIOCONJUGATE CHEMISTRY
- An efficient chemical approach to bispecific antibodies and antibodies of high valency
- (2009) Julia I. Gavrilyuk et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Treatment in advanced colorectal cancer: what, when and how?
- (2009) I Chau et al. BRITISH JOURNAL OF CANCER
- Targeted Cancer Therapeutics
- (2009) William N. Hait CANCER RESEARCH
- Angiopoietin-2 Levels Are Associated with Disease Progression in Metastatic Malignant Melanoma
- (2009) I. Helfrich et al. CLINICAL CANCER RESEARCH
- Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation
- (2009) Konstantin J. Dedes et al. EUROPEAN JOURNAL OF CANCER
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site
- (2009) J. Bostrom et al. SCIENCE
- Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro
- (2008) M K Robinson et al. BRITISH JOURNAL OF CANCER
- Targeting the VEGF pathway: Antiangiogenic strategies in the treatment of non-small cell lung cancer
- (2008) Marianna Aita et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted Therapies for the Treatment of Breast Cancer in the Post-trastuzumab Era
- (2008) F. Petrelli et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now